日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Histone Methyltransferase Inhibitor A-366 Uncovers a Role for G9a/GLP in the Epigenetics of Leukemia

组蛋白甲基转移酶抑制剂 A-366 揭示 G9a/GLP 在白血病表观遗传学中的作用

William N Pappano, Jun Guo, Yupeng He, Debra Ferguson, Sujatha Jagadeeswaran, Donald J Osterling, Wenqing Gao, Julie K Spence, Marina Pliushchev, Ramzi F Sweis, Fritz G Buchanan, Michael R Michaelides, Alexander R Shoemaker, Chris Tse, Gary G Chiang

Iniparib nonselectively modifies cysteine-containing proteins in tumor cells and is not a bona fide PARP inhibitor

Iniparib 非选择性地修饰肿瘤细胞中的半胱氨酸蛋白,并不是真正的 PARP 抑制剂

Xuesong Liu, Yan Shi, David X Maag, Joann P Palma, Melanie J Patterson, Paul A Ellis, Bruce W Surber, Damien B Ready, Niru B Soni, Uri S Ladror, Allison J Xu, Ramesh Iyer, John E Harlan, Larry R Solomon, Cherrie K Donawho, Thomas D Penning, Eric F Johnson, Alexander R Shoemaker

The Bcl-2/Bcl-X(L)/Bcl-w inhibitor, navitoclax, enhances the activity of chemotherapeutic agents in vitro and in vivo

Bcl-2/Bcl-X(L)/Bcl-w 抑制剂 navitoclax 可增强化疗药物在体内和体外的活性

Jun Chen, Sha Jin, Vivek Abraham, Xiaoli Huang, Bernard Liu, Michael J Mitten, Paul Nimmer, Xiaoyu Lin, Morey Smith, Yu Shen, Alexander R Shoemaker, Stephen K Tahir, Haichao Zhang, Scott L Ackler, Saul H Rosenberg, Heather Maecker, Deepak Sampath, Joel D Leverson, Chris Tse, Steven W Elmore